RHY 1.65% 9.3¢ rhythm biosciences limited

Ann: Appendix 4C, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 93 Posts.
    lightbulb Created with Sketch. 29
    Nothing not to like here. A good update. Costs in check and plenty of cash in the bank. Development milestones hit on time and on budget. They did mention in a previous update about recruiting patients for trial 7 in Q1 ‘19. It seems they need to upscale and finalise kit development and commence trial 6 (concurrently?) before that will happen so it’s likely a ways down the track. Rhy is the long game and I’m sure there’s a lot going on behind the scenes and Rhythm are building relationships with partners, government and the healthcare community to make Colostat a reality. Hopefully regular updates to follow...
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
9.3¢
Change
0.002(1.65%)
Mkt cap ! $15.41M
Open High Low Value Volume
9.0¢ 9.4¢ 9.0¢ $71.56K 768.2K

Buyers (Bids)

No. Vol. Price($)
3 157347 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.3¢ 21660 2
View Market Depth
Last trade - 12.33pm 29/11/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.